3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
4
Depression
4
Head and Neck Neoplasms
3
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Fatigue
2
Anxiety Disorders
2
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Sleep Wake Disorders
1
Recurrence
1
Radiation Fibrosis Syndrome
1
Prostatic Neoplasms
1
Prostatic Hyperplasia
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Patient Acceptance of Health Care
1
Pain
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Calculi
1
Inflammatory Breast Neoplasms
1
Immune Checkpoint Inhibitor-Induced Dermatitis
1
Health Education
1
Constriction, Pathologic
1
Interventions
Temozolomide
40
Magnetic Resonance Spectroscopy
19
Radiotherapy
18
Specimen Handling
14
Radiation
12
Bevacizumab
11
Lomustine
9
pembrolizumab
6
fludarabine
5
Surgical Procedures, Operative
5
atezolizumab
4
Nivolumab
4
Ipilimumab
4
Cyclophosphamide
4
Carboplatin
4
Biopsy
4
cemiplimab
3
azeliragon
3
Immunoglobulin G
3
Disulfides
3
Aminolevulinic Acid
3
veliparib
2
trametinib
2
rocakinogene sifuplasmid
2
poly ICLC
2
olaparib
2
lutetium Lu 177 dotatate
2
durvalumab
2
dabrafenib
2
contrast agent BR1
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioblastoma
×
Therapeutics
×
90 days
×
Clear all
No trials found.